ERIN KEANE: Open Payments
NPI 1215611900 · BENSALEM, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,416 in 104 payments from 19 companies in 2025. Trend: 2023 $92 · 2024 $1,345 · 2025 $2,416
Food & beverage: $2,416
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $575 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $400 |
| Janssen Biotech, Inc. | 8 | $248 |
| Gilead Sciences, Inc. | 8 | $208 |
| Madrigal Pharmaceuticals | 2 | $152 |
| GENZYME CORPORATION | 5 | $144 |
| Ardelyx, Inc. | 5 | $104 |
| QOL Medical, LLC | 5 | $99 |
| Lilly USA, LLC | 4 | $83 |
| Braintree Laboratories, Inc. | 2 | $79 |
Products named: RINVOQ, ENTYVIO, TREMFYA, DUPIXENT, REZDIFFRA, EOHILIA, MAVYRET, Livdelzi.
Industry payments across PA — which companies pay providers there.
